2021, "Top Doctor", Boston Magazine
2020, Planning Committee for Nutrition during Pregnancy and Lactation -Exploring New Evidence- A Workshop, National Academy of Science, Engineering and Medicine
2019, Data Safety Monitoring Board, Maternal Fetal Medicine Units
2019, Perinatal Research Society 50th anniversary meeting, March of Dimes Nutrition Lecture
2018, Gail Anderson-Phil Manning Invited Lecture; Endocrine Disease in Pregnancy
2014, Appointed Inaugural Dierker-Biscotti Professor of Women’s Health and Wellness
2012, Macy Nigh-Whitener Professorship, Children’s Hospital Foundation, University of Oklahoma
2012, University of Toronto Charles H Best Lecture, for outstanding contributions to research in diabetes Toronto Canada
2012, University of Toronto, Henderson lecture, Dept. of Obstetrics and Gynecology
2011, Jorgen Pederson Lecturer, Diabetes in Pregnancy Study Group of the European Association for the Study of Diabetes
2011, March of Dimes Agnes Higgins Award, in Recognition of Service to the Cause of Improved Maternal Nutrition
2010, Elected by peers for inclusion in the “Best Doctors in America” from 2001-2012 Co-Chair of the NICHD Vision Workshop: pregnancy
2010, Group leader of the NICHD Vision Workshop; Developmental Origins of Health and Disease
2005, Distinguished Academic Achievement Award from the Medical Alumni Association of the University of Vermont College of Medicine in Burlington, VT
2004-2006, Chair, American Diabetes Association, Pregnancy and Women’s Health Council
2001-2012, Elected by peers for inclusion in the “Best Doctors in America”
2000, Norbert Freinkel Lecture Outstanding Research in the Field of Diabetes in Pregnancy
1997, President, Perinatal Research Society
1994, National Faculty Award for Excellence in Resident Education, Council on Resident Education in Obstetrics and Gynecology
1993, Department of Obstetrics and Gynecology, MetroHealth Medical Center, Teacher of the Year Award
1983 American College of Obstetrics and Gynecology Maternal Fetal Medicine Sam Seeds Research Fellowship Award
1982 Junior Fellow of American College of Obstetrics and Gynecology, Clinical Research Award Sponsored by Mead Johnson
1975 Moses Dyer Carbee Prize
For a complete list of Dr. Catalano's publications, see here: Full list
Catalano PM, Tyzbir ED, Wolfe RR, Calles JE, Roman NM, Amini SB, Sims EAH. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol 264 (Endocrinol Metab 27): E60-67, 1993.
Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903-16, 1999.
Catalano PM, Nizielski SE, Shao J, Presley L, Qiao L, Friedman JE. Downregulated IRS-1 and PPAR gamma in obese women with gestational diabetes: Relationship to free fatty acids during pregnancy. Am J Physiology (Endocrine Metab) 282: E522-33, 2002.
Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: A very sensitive marker of abnormal in-utero development. Am J Obstet & Gynecol 189:1698-704, 2003.
Catalano P, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 32:1076-80, 2009.
Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, Hauguel-de Mouzon S, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 90:1303-13, 2009.
Lassance L, Haghiac M, Leahy P, Basu S, Minium J, Zhou J, Reider M, Catalano PM, Hauguel-de Mouzon S. Identification of early transcriptome signatures in placenta exposed to insulin and obesity. Am J Obstet Gynecol 212:647.e1-11, 2015.
Ma RC, Schmidt MI, Tam WH, McIntyre HD, Catalano PM. Clinical management of pregnancy in the obese mother: before conception, during pregnancy, and postpartum. Lancet Diabetes Endocrinol 4:1037-1049, 2016.
Catalano P, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 356:j1, doi: 10.1136/bmj.j1 2017.
Lowe WL Jr, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O, Catalano PM, Linder B, Brickman WJ, Clayton P, Deerochanawong C, Hamilton J, Josefson JL, Lashley M, Lawrence JM, Lebenthal Y, Ma R, Maresh M, McCance D, Tam WH, Sacks DA, Dyer AR, Metzger BE; HAPO Follow-up Study Cooperative Research Group. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 2320:1005-1016, 2018.
Powe CE, Huston Presley LP, Locascio JJ, Catalano PM. Augmented insulin secretory response in early pregnancy. Diabetologia 62:1445-145, 2019.
Josefson JL, Catalano PM, Lowe WL, Scholtens DM, Kuang A, Dyer AR, Lowe LP, Metzger BE. The joint associations of maternal BMI and glycemia with childhood adiposity. J Clin Endocrinol Metab 105:2177-2188, 2020.
Erickson ML, Mey JT, Axelrod CL, Paul D, Gordesky K, Russell K, Barkoukis HP, O'Tierney-Ginn P, Fielding RA, Kirwan JP, Catalano PM. Rationale and study design for lifestyle intervention in preparation for pregnancy (LIPP): A randomized controlled trial. Contemp Clin. Trials 94:106024, 2020.
Patrick Catalano MD is a Professor and Vice Chair of Obstetrics and Gynecology at Tufts University School of Medicine and a Maternal -Fetal Medicine specialist at Tufts University Medical Center. His research is focused on maternal metabolism in women whose pregnancies are complicated by diabetes and obesity. Further he is studying the short and long-term effects on mothers and their children. He has had continuous funding from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development for the past 30 year
The Impact of Lifestyle Interventions Prior to Pregnancy on Maternal and Neonatal Adipocyte Metabolism
The goal of this grant is to investigate the longitudinal effects of pregravid lifestyle interventions on maternal at metabolic function and neonatal adiposity and examine potential early biomarkers and mechanisms as predictors of long-term metabolic outcomes in the offspring.
NIH/NIDDK U01 DK123795-01
Measuring Early Pregnancy Glycemia and Its Impact on Adverse Outcomes
The objective of this proposal is a prospective observational study to examine glucose physiology during pregnancy.
Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir (ORCHID)
The overall purpose of this grant is to understand how dolutegravir (DTG) use during pregnancy affects the metabolic health of women and their children.
Tufts Institute for Global Obesity Research (TIGOR)
Determine the longitudinal metabolomic profile of overweight and obese women undergoing lifestyle interventions to decrease weight before and during pregnancy and delivery.
Tufts-IRACDA NIGMS, K12GM133314
The impact of lifestyle interventions prior to pregnancy on maternal and neonatal adipocyte metabolism
The goal of the project is to determine how maternal adipose tissue function and neonatal stem cell metabolism improve after pregravid lifestyle intervention, with the purpose of examining potential biomarkers as predictors of long-term metabolic health in the offspring.
2019 – 2024
Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance.
The overall goal of this proposal is to continue studies on plasma glycated CD59 (pGCD59) as a novel biomarker for gestational diabetes mellitus (GDM). Human studies indicate that pGCD59 is a sensitive biomarker of pregnancy-induced glucose intolerance1and is a molecular link between glycation inactivation of CD59 and the complications of GDM.
2019 – 2024
Kisspeptin: A novel Regulator of Insulin sensitivity in Pregnancy.
The goal of this project is to provide a comprehensive five-year training program for mentored career development in patient-oriented research for the PI, including independent clinical trials, specifically constructed to provide focused training pregnancy physiology and in the mechanisms of insulin physiology
Tufts Collaborative Grant
2019 – 2020
Infant feeding and early childhood adiposity: identifying targets for future intervention.
The overall goal is to investigate the relationship between maternal BMI, maternal infant feeding style and infant adiposity and to examine mediators or moderators of the maternal infant feeding style and infant adiposity relationship.
NIH/NICHD R01 HD091054
Placental Lipid Metabolism Impacts Fetal Adiposity and is Programmed by the Maternal Metabolic Milieu in Early Pregnancy.
Goals: To determine how maternal fat metabolism in early pregnancy programs placental lipid metabolism and neonatal fat deposition.
Level and Timing of Diabetic Hyperglycemia in utero: The Transgenerational Effect on Adult Morbidity (TEAM Study).
The objective of this proposal is to combine data from research conducted on a cohort of women with pregestational diabetes and follow-up of their offspring to elucidate the effect of exposure to hyperglycemia in utero on a spectrum of metabolic diseases and cardiovascular dysfunction.
NIH/NICHD R01 HD091735
Placental miRNA Profiles Associated with Maternal Insulin Resistance and Fetal Adiposity: Maternal-Placental Crosstalk.
Goals: To determine the association between miRNA originating in the placenta with maternal insulin resistance and fetal adiposity.
NIH/NICHD NIH HD 088061-01A1
Lifestyle Intervention in Preparation for Pregnancy. Click to view grant
The objective of this project is to break the vicious cycle of obesity/metabolic dysfunction during pregnancy to decrease the risk of maternal and neonatal perinatal morbidity. The primary aim is to decrease adiposity at birth in infants of overweight/obese women through lifestyle intervention of behavioral modification, healthy eating and exercise before a planned pregnancy using a RCT in women after their first pregnancy.
Role: Principal Investigator
NIH/NICHD NIH HD 079647
Comparison of Two Screening Strategies for Gestational Diabetes. The study will examine the current ACOG and IADPSG screening strategies for the diagnosis of gestational diabetes based on clinical outcomes. Outcomes include if either screening and treatment strategy results in healthier infants and mothers.
NIH/NIDDK NIH R8S119091
Hyperglycemia and Adverse Pregnancy Outcome-Follow up Study (HAPO-FUS).
The HAPO-FUS will evaluate the mothers who participated in the original HAPO study and their offspring at 8-12 years of age.
The purpose of the study is to evaluate maternal obesity and glucose tolerance during pregnancy as risk factors for metabolic dysfunction in the mother and her offspring.
Role: Principal Investigator at the MetroHealth site/Vice Chair Executive Committee
Past Grants Download PDF
Obstetrics and Gynecology
Journal of Pediatrics
American Journal of Perinatology
American Journal of Obstetrics and Gynecology
Journal of Reproductive Medicine
American Journal of Clinical Nutrition
Journal of Maternal-Fetal Medicine
American Journal of Physiology (Editorial Board)
Journal of the Society for Gynecologic Investigation
New England Journal of Medicine
Journal of the American Medical Association (JAMA)
Diabetes (Editorial Board)
Early Human Development
Journal of Clinical Endocrinology and Metabolism (Editorial Board)
Lancet, Diabetes and Endocrinology
European Journal of Clinical Nutrition
European Journal of Endocrinology
European Journal of Obstetrics and Gynecology and Reproductive Biology
Journal of Perinatology
Journal of Pediatric Obesity/Obesity
Nature Clinical Practice Endocrinology and Metabolism
British Journal of Nutrition
Maternal and Child Health Journal
Gynecologic and Obstetric Investigation
Paediatric and Perinatal Epidemiology
Journal of Obesity
Journal of Women’s Health
Expert Review of Endocrinology and Metabolism
Trends in Endocrinology and Metabolism
International Journal of Obesity
British Medical Journal
Applied Physiology, Nutrition and Metabolism
Journal of Nutrition and Metabolism
Journal of Nutrition
Public Health Reports